Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H24F3N3O4 |
Molecular Weight | 439.4282 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C2N(CCF)C=C(C(O)=O)C(=O)C2=CC(F)=C1N3C[C@@H](F)[C@@H](CNC4CC4)C3
InChI
InChIKey=ZFIOCUITTUUVPV-MEDUHNTESA-N
InChI=1S/C21H24F3N3O4/c1-31-20-17-13(19(28)14(21(29)30)9-26(17)5-4-22)6-15(23)18(20)27-8-11(16(24)10-27)7-25-12-2-3-12/h6,9,11-12,16,25H,2-5,7-8,10H2,1H3,(H,29,30)/t11-,16+/m0/s1
Molecular Formula | C21H24F3N3O4 |
Molecular Weight | 439.4282 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:41:47 GMT 2023
by
admin
on
Fri Dec 15 16:41:47 GMT 2023
|
Record UNII |
55MOB566V7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5370
Created by
admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
|
PRIMARY | |||
|
Lascufloxacin
Created by
admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
|
PRIMARY | |||
|
300000019094
Created by
admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
|
PRIMARY | |||
|
71528768
Created by
admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
|
PRIMARY | |||
|
10017
Created by
admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
|
PRIMARY | |||
|
DTXSID001336967
Created by
admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
|
PRIMARY | |||
|
848416-07-9
Created by
admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
|
PRIMARY | |||
|
C166817
Created by
admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
|
PRIMARY | |||
|
55MOB566V7
Created by
admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|